Research article · 5 Jun 2017
Conference abstractPublished 20 Nov 2013
Yin and Yang of the Fas pathway in regulating self-tolerance
Johns Hopkins University School of Medicine, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Type1 diabetes (T1D) results from autoimmune destruction of pancreatic insulin-producing Ã?Â?-cells. Autoreactive T cells are activated by islet autoantigens in pancreatic lymph nodes (PLN) from where they infiltrate pancreatic islets of Langerhans to cause insulitis and Ã?Â?-cell destruction. Although present within the normal repertoire of healthy individuals, autoreactive T cells are held in check by suppressive cytokines and specialized subsets of regulatory cells. In disease-susceptible individuals and the widely used âÂ?Â?non-obese diabetic (NOD) mouse model,âÂ? these immunoregulatory mechanisms fail, thereby permitting diabetogenic T cells to infiltrate islets, cause insulitis, and destroy Ã?Â?-cells. What causes these mechanisms to fail and how the failures can be avoided/rectified are current questions of paramount scientific and clinical significance. Our group is interested in understanding mechanisms that potently control Ã?Â?-cell-specific autoreactive T-cells when Fas ligand (FasL), an apoptosisinducing member of the tumor necrosis factor (TNF) family, is genetically or pharmacologically inactivated. Disruption of the Fas pathway causes massive T cell lymphoproliferation but instead of causing or aggravating organ specific autoimmunity, as is the case with CTLA-4 or Foxp3 deficiency, it restores organ-specific T cell tolerance in several autoimmune models. This paradox is best illustrated in NOD mice carrying homozygous gld or lpr mutations. Our mouse data support the hypothesis that defects in IL-10 utilization underlie autoimmune diabetes and that IL-10- producing B cells induced in pancreata by inactivating FasL are capable of controlling diabetogenic T cells. We will discuss the role of FasL in compromising and negating the role of IL-10 in antagonizing the diabetogenic process especially at the effector site, the pancreas.
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 2020
Transcriptional regulation of the genes involved in skin-regeneration using protein delivery Jee-Eun Yang
Conference abstract · 15 Jun 2022
Malignance Cell Grade Regression in Patient with Prostate Cancer Caused by Imbalances of Yin and Yang Energy
Research article · 30 Jan 2021
The Yins and Yangs of Automation in Supply Chain
Case report · 20 Oct 2020
Yin - yang: the reason for abdominal pain?
More from this journal
The newest in Journal of Cell Science & Therapy.
Perspective · 2 Feb 2026
Exploring Senescence and Its Influence on Tissue Function and Therapeutic Research
Commentary · 2 Feb 2026
Metabolism Regulation and Its Influence on Therapeutic Development in Human Disease
Commentary · 2 Dec 2025
Cellular Membranes and Transport Proteins as Regulators of Homeostasis and Metabolic Coordination
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cell Science & Therapy
- SubjectBiology
- BylineArticles whose byline prints “Abdel Rahim A. Hamad”

